Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
immuno-oncology
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma
Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
Posted inMergers & Acquisitions, Oncology
Takeda Bets on Promising Gamma Delta T-cell Immunotherapy
UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.
Posted inOncology, Regulatory
Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer and Esophageal Cancer
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory
Small Cell Lung Cancer: Let Immunotherapy Help!
A deadly disease and modern pharmacological attempts to treat it.
Posted inOncology, Research
Not All Cancer Drugs Are Equally Useful
Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.
